Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
about
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@ast
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@en
type
label
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@ast
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@en
prefLabel
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@ast
Early BCR-ABL1 Transcript Decl ...... e in Chronic Myeloid Leukemia.
@en
P2093
P2860
P50
P1433
P1476
Early BCR-ABL1 Transcript Decl ...... se in Chronic Myeloid Leukemia
@en
P2093
Henrik Hjorth-Hansen
Johan Richter
Leif Stenke
Mohamed El Missiry
Ulla Olson-Strömberg
P2860
P304
P356
10.1371/JOURNAL.PONE.0171041
P407
P577
2017-01-30T00:00:00Z